For years, the idea of adults growing taller seemed like a fantasy. However, advancements in medical science have made this ...
The Phase 3 trial is scheduled to begin in the first quarter of fiscal year 2026 and conclude within fiscal year 2027. Since this drug has received orphan drug designation from the Ministry of Health, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback